News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Hagop Kantarjian: In this Ph1b trial, single agent SQ blinatumomab resulted in a high MRD-negative complete remission rate
Photo taken from: Hagop Kantarjian/X
Feb 18, 2024, 15:51

Hagop Kantarjian: In this Ph1b trial, single agent SQ blinatumomab resulted in a high MRD-negative complete remission rate

Hagop Kantarjian, Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, shared on X:

“In this Ph1b trial, single agent SQ blinatumomab resulted in a high MRD-negative complete remission rate & an acceptable safety profile in heavily pretreated adults w/ R/R B-ALL
Elias Jabbour of MD Anderson Cancer Center”

Read further.
Source: Hagop Kantarjian/X

cancer clinical trial Elias Jabbour Hagop Kantarjian MD Anderson Cancer Center OncoDaily Oncology Research
Special Coverage
Blog
Dec 19, 2024, 02:54
Bladder-Sparing Strategies for MIBC: Insights from Professor Ming Cao at ESMO Asia2024
Blog
Dec 19, 2024, 02:52
Vicki Kennedy: The critical importance of psychosocial oncology standards
Blog
Dec 19, 2024, 02:47
Liver cancer treatment through radioembolization - IMAGIO
Blog
Dec 19, 2024, 02:43
Paolo Tarantino: The highly awaited Breast Cancer trials with positive results
Blog
Dec 19, 2024, 02:34
Javier Muñoz Carrillo: First-hand presentation of cutting-edge clinical trial results in breast cancer research at SABCS24
Science
Dec 19, 2024, 02:31
Laura Bukavina: Use of Perioperative Immunotherapy and TKI in RCC with IVC thrombus patients by Kotaro Suzuki et al.
Science
Dec 19, 2024, 02:26
Nicholas Hornstein: CtDNA for Appendiceal Adenocarcinoma is not as robust as in Colorectal Cancer
Blog
Dec 19, 2024, 02:20
Sathgen Therapeutics Named Company of the Year 2024 by Silicon India Magazine
Blog
Dec 19, 2024, 02:19
Cancer costs the average patient in Canada nearly $33,000 in their lifetime - Canadian Cancer Society
Blog
Dec 19, 2024, 02:17
Living with Blood Cancer makes time precious and more urgent - The Leukemia and Lymphoma Society
Blog
Dec 19, 2024, 02:16
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research - NCI Division of Cancer Prevention
Blog
Dec 19, 2024, 02:11
An upcoming FDA-AACR workshop on DPD deficiency testing